Serina Therapeutics
NYSE SER · Huntsville, AL
Works in Neurology
Serina Therapeutics is a clinical trial sponsor based in Huntsville, AL, listed as NYSE SER. It has 1 active clinical trial with 40 planned participants, in Neurology.
Trial track record · since 2021
Financials · NYSE SER
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Serina Therapeutics
Serina Therapeutics is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 40 planned participants, in Neurology. Since 2021 it has completed 0 trials and stopped 0 early.
Serina Therapeutics is based in Huntsville, AL and is listed as NYSE SER. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Serina Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-06-05.
Approve Suite is not affiliated with Serina Therapeutics. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.